

Oplos Medicare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 5.00 M
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 3.40 Cr
- Revenue Growth 53.98%
- Profit Growth 12.84%
- Ebitda 69.55%
- Net Worth 4.06%
- Total Assets 14.24%
About Oplos Medicare Pharmaceuticals
Oplos Medicare Pharmaceuticals Private Limited (OMPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 February 2010 and has a history of 15 years and three months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.40 Cr.
Vaibhav Vohra and Arpit Vohra serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100DL2010PTC198803
- Company No.
198803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2010
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Oplos Medicare Pharmaceuticals Private Limited offer?
Oplos Medicare Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements.
Who are the key members and board of directors at Oplos Medicare Pharmaceuticals?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vaibhav Vohra ![]() | Whole-Time Director | 08-Feb-2010 | Current |
Arpit Vohra ![]() | Whole-Time Director | 08-Feb-2010 | Current |
Financial Performance of Oplos Medicare Pharmaceuticals.
Oplos Medicare Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 53.98% increase. The company also saw a substantial improvement in profitability, with a 12.84% increase in profit. The company's net worth moved up by a moderate rise of 4.06%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Oplos Medicare Pharmaceuticals?
In 2019, Oplos Medicare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Pureca Laboratories Private Limited
Vaibhav Vohra and Arpit Vohra are mutual person
- Dinkum Biological Private Limited
Arpit Vohra is a mutual person
Charges (Loans)
₹3.40 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 2.40 Cr
- Punjab National Bank : 1.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
04 May 2017 | Others | ₹2.40 Cr | Open |
19 May 2011 | Punjab National Bank | ₹1.00 Cr | Open |
How Many Employees Work at Oplos Medicare Pharmaceuticals?
Unlock and access historical data on people associated with Oplos Medicare Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Oplos Medicare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oplos Medicare Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Oplos Medicare Pharmaceuticals
Recent activity within the organization
- Charges
A charge with Others of Rs. 2.40 Cr registered on 04 May 2017 with Charge ID 100116339 was modified on 14 Aug 2020.
- Annual General Meeting
Oplos Medicare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
- Balance Sheet
Oplos Medicare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi.
- Charges
A charge with Others amounted to Rs. 2.40 Cr with Charge ID 100116339 was registered on 04 May 2017.
- Charges
A charge with Punjab National Bank of Rs. 1.00 Cr registered on 19 May 2011 with Charge ID 10292044 was modified on 14 Jul 2015.
- Charges
A charge with Punjab National Bank amounted to Rs. 1.00 Cr with Charge ID 10292044 was registered on 19 May 2011.
Frequently asked questions
What is the Incorporation or founding date of Oplos Medicare Pharmaceuticals Private Limited?
Oplos Medicare Pharmaceuticals Private Limited was incorporated on 08 Feb 2010.
What is authorized share capital and paid-up capital of Oplos Medicare Pharmaceuticals Private Limited?
The authorized share capital of Oplos Medicare Pharmaceuticals Private Limited is ₹ 1.00 Cr and paid-up capital is ₹ 5.00 M.
Who are the current board members & directors of Oplos Medicare Pharmaceuticals Private Limited?
Currently 2 directors are associated with Oplos Medicare Pharmaceuticals Private Limited.
- Vaibhav Vohra
- Arpit Vohra
What is the registered address of Oplos Medicare Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Oplos Medicare Pharmaceuticals Private Limited is Plot No-59 Basement Pkt-B Sector-4 Dsiidc, Bawana India, Delhi, 110039.
What is the corporate identification number (CIN) and company number of Oplos Medicare Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Oplos Medicare Pharmaceuticals Private Limited is U24100DL2010PTC198803 and the company number is 198803 as per Ministry of Corporate Affairs (MCA).
What is the official website of Oplos Medicare Pharmaceuticals Private Limited?
The Official website of Oplos Medicare Pharmaceuticals Private Limited is https://www.oplosmedicare.com
What has been the recent revenue trend for Oplos Medicare Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2019, the revenue trend for Oplos Medicare Pharmaceuticals Private Limited has risen by 53.98%.
What change has been observed in the net worth of Oplos Medicare Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2019 indicates that The net worth of Oplos Medicare Pharmaceuticals Private Limited has experienced an upsurge of 4.06%.
What are the total open charges for Oplos Medicare Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2019, The total open charges for Oplos Medicare Pharmaceuticals Private Limited amount to ₹ 3.40 Cr.
When was the last Balance Sheet of Oplos Medicare Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Oplos Medicare Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2019.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
SV
Subhash VohraWholetime Director
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India